4//SEC Filing
TYNDALL JOSEPH A. 4
Accession 0000805928-25-000166
CIK 0000805928other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 5:20 PM ET
Size
13.9 KB
Accession
0000805928-25-000166
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
TYNDALL JOSEPH A.
Director
Transactions
- Exercise/Conversion
Common Stock
2025-12-09$7.04/sh+14,248$100,306→ 14,248 total - Exercise/Conversion
Common Stock
2025-12-09$10.95/sh+10,860$118,917→ 25,108 total - Sale
Common Stock
2025-12-09$30.98/sh−14,248$441,360→ 10,860 total - Sale
Common Stock
2025-12-09$30.98/sh−10,860$336,410→ 0 total - Exercise/Conversion
Employee Stock Option (right to purchase)
2025-12-09−14,248→ 0 totalExercise: $7.04Exp: 2034-06-06→ Common Stock (14,248 underlying) - Exercise/Conversion
Stock Option (right to purchase)
2025-12-09−10,860→ 32,311 totalExercise: $10.95Exp: 2032-12-13→ Common Stock (10,860 underlying)
Footnotes (3)
- [F1]The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.485 to $31.305 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]Non-qualified stock option portion of the 2024 annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The grant vested on June 6, 2025, the one-year anniversary of the grant date.
- [F3]Option grant for joining the Issuer's Board of Directors. Options vest in three equal annual installments on the annual anniversary of the grant date with the first vesting date occurring on December 13, 2023.
Documents
Issuer
Axogen, Inc.
CIK 0000805928
Entity typeother
Related Parties
1- filerCIK 0001955281
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 5:20 PM ET
- Size
- 13.9 KB